Organicell Regenerative Medicine, Inc. company info

CIK 1557376
IRS Number 474180540
State of incorporation None
Business address 4045 SHERIDAN AVENUE
SUITE 239
MIAMI
FL
33140
Mail address 4045 SHERIDAN AVENUE
SUITE 239
MIAMI
FL
33140

Short summary

Organicell Regenerative Medicine, Inc. is a Florida company, with head office located at 4045 Sheridan Avenue Miami, Florida 33140. In 2017 the company owned a total of 376.78 thousand USD worth of assets, including 281.08 thousand USD worth of current assets. The company amassed the most assets last year, totalling up to 376.78 thousand USD.

Organicell Regenerative Medicine, Inc. Income Statement

Name [in Millions USD]2011201220132014201520162017Trends
Cost of Goods and Services Sold 0.010.060.04
Gross Profit 0.010.030.040.100.090.41
Operating Expenses 0.020.040.070.091.139.05
Operating Income (Loss) -0.74-1.04-8.64
Interest expense 0.010.58
Other Nonoperating Income (Expense) 00.01
Income Tax Expense (Benefit) 0
Net income -0.01-0.01-0.03-0.06-0.74-1.25-8.97

Organicell Regenerative Medicine, Inc. Balance Sheet

Name [in Millions USD]2011201220132014201520162017Trends
Accounts Receivable, Net, Current 0.000.080.11
Inventories 0.010.010.110.12
Property, Plant and Equipment, Gross 0.000.050.07
Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment 0.000.010.02
Total assets 0.020.020.020.020.050.340.38
Current assets 0.040.010.050.300.28
Non-current assets 0.00
Accounts payable 0.010.010.020.010.01
Total current liabilities 0.010.010.050.070.482.243.88
Total liabilities 0.070.390.85
Common Stock, Value, Issued 0.010.010.010.010.100.110.11
Retained Earnings (Accumulated Deficit) -0.01-0.03-0.10-0.15-1.47-9.27-11.09
Accumulated Other Comprehensive Income (Loss), Net of Tax 0.00

Organicell Regenerative Medicine, Inc. Cash Flow

Name [in Millions USD]2011201220132014201520162017Trends
Net income -0.01-0.01-0.03-0.06-0.74-1.25-8.97
Depreciation 00.000.000.02
Accounts receivable 0.02-0.020.11
Inventories -0.01-0.01-0.000.010.11
Accounts payable 0.010.010.01-0.02
Deferred revenue 0.02-0.020.08
Net Cash Provided by (Used in) Operating Activities -0.01-0.01-0.03-0.06-0.45-0.55-0.88
Payments to Acquire Property, Plant, and Equipment 0.010.030.05
Net Cash Provided by (Used in) Investing Activities -0.01-0.02-0.05
Net Cash Provided by (Used in) Investing Activities, Continuing Operations -0.01-0.03-0.05
Stock Issued During Period, Value, Share-based Compensation, Net of Forfeitures 0.275.82
Stock Issued During Period, Value, Share-based Compensation, Net of Forfeitures 0.275.82
Proceeds from Issuance of Common Stock 0.030.040.500.460.40
Net Cash Provided by (Used in) Financing Activities 0.0300.040.050.490.560.94